期刊文献+

海洛因依赖者血清中IL-9、IL-17水平的研究 被引量:2

A Study on the level of IL-9,IL-17 in Sera from Heroin Addicts
下载PDF
导出
摘要 目的:通过检测IL-9、IL-17在海洛因依赖者血清中水平的变化,为进一步认识海洛因对机体免疫功能的影响提供依据。方法:93例海洛因依赖者按吸食海洛因时间长短分为三组(2年以内、510年、10年以上),31例正常人血清作为对照组,用双抗体夹心酶联免疫吸附试验(ELISA)检测各组血清IL-9、IL-17水平。结果:2年以内组和510年组海洛因依赖者血清IL-9较正常对照升高(P〈0.05)、各组IL-17水平较正常对照组降低(P〈0.05);从2年以内组到510年组到10年以上组,IL-9水平先升高后降低[(334.92±144.41)pg/ml、(353.47±176.93)pg/ml、(287.38±129.94 pg/ml)],IL-17水平先降低后相对升高[(53.38±26.08)pg/ml、(45.87±16.81)pg/ml、(68.18±39.26)pg/ml)]。结论:IL-9、IL-17在海洛因依赖者血清中水平改变明显,吸食海洛因可刺激IL-9水平升高而抑制机体IL-17的水平表达。 Objective:By detecting IL-9,IL-17 in serum levels of heroin addicts change for a further exploration of heroin's effects on immune function to provide evidence.Methods:93 cases of heroin addicts were equally divided into 3 groups as those who employed to detect their sera levels IL-9,IL-17,31 cases of normal human sera were used as controls.Results:The groups of heroin addicts that had taken for less than 2 years and that had taken for 5 to 10 years had higher levels of IL-9(P〈0.05) but lower levels of IL-17(P〈0.05),both compared to the controls.The levels of IL-9 rose at first but then went down over the range of all groups in the order of drug-taking durations(334.92±144.41 pg/ml,353.47±176.93 pg/ml,287.38±129.94 pg/ml);while the levels of IL-17 had the opposite story,falling down firstly but ascending afterwards(53.38±26.08 pg/ml,45.87±16.81 pg/ml,68.18±39.26 pg/ml).Conclusion:The levels of IL-9,IL-17 in the sera from the heroin addicts changed significantly.Heroin abuses were proved to stimulate the expression of IL-9 but inhibit that of IL-17 in vivo.
作者 何军 左丽
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第5期463-465,共3页 Chinese Journal of Immunology
关键词 海洛因依赖者 IL-9 IL-17 免疫功能 Heroin addicts IL-9 IL- 17 Immunefuction
  • 相关文献

参考文献10

  • 1Islam S K,Hossain K J,Kamal M et al.Serum immunoglobulins and white blood cells status of drug addicts:influence of illicit drugs and sex habit[J].Addict Biol,2004;9(1):27-33.
  • 2Ran D,Goldman.Drug-induced gynecomastia in children and adolescents[J].Can Fam Physician,2010;56:344-345.
  • 3Vallqo R,Benyamin R.Opioid therapy and immunosuppression:a review[J].Am J Ther,2004;11(5):354-365.
  • 4Timothy B,Saurer,Stephanie G et al.Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations[J].Pharmacol Exp Ther,2009;329:1040-1047.
  • 5Dodd Jonathan S,Lum Eda C,Goulding John et al.IL-9 Regulates pathology during primary and memory responses to respiratory syncytial virus infection[J].Immunol,2009;183(11):7006-7013.
  • 6Nowak E C,Weaver C T,Henrietta Turner et al.IL-9 as a mediator of Th17-driven inflammatory disease[J].Exp Med,2009;206:1653-1660.
  • 7Betteli E,Carrier Y,Gao W et al.Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regμlatory T cells[J].Nature,2006;441(7090):235-238.
  • 8张玉侠.效应分子IL-17的抗感染作用[J].国际免疫学杂志,2009,32(3):241-244. 被引量:6
  • 9Curtis M M,Way S S.Interleukin-17 in host defense against bacterial,mycobacterial and fungal pathogens[J].Immunology,2009;126(2):177-185.
  • 10Wassim Elyaman,Elizabeth M,Bradshaw et al.IL-9 induces differentiation of Th17 cells and enhances function of FoxP3+ natural regulatory T cells[J].PNAS,2009;106:12885-12890.

二级参考文献34

  • 1Harrington LE, Hatton RD, Mangan PR,et al. Interleukin 17-producing CD^+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol,2005,6( 11 ) :1023- 1070.
  • 2Weaver CT, Harrington LE, Mangan PR, et al. Th17:an effector CD4 T cell lineage with regulatory T cell ties. Immunity, 2006,24 (6) :677-688.
  • 3Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature,2006,441 (7090) :235-238.
  • 4Ghilardi N, Kljavin N, Chen Q, et al . Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol,2004,172 ( 5 ) :2827-2833.
  • 5Liang SC,Tan XY, Luxenberg DP, et al. Interleukin (IL) -22 and IL-17 are coexpressed by Thl7 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med, 2006,203 ( 10 ) : 2271-2279.
  • 6Curtis MM, Way SS. Interleukin.17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology, 2009, 126 (2) :177-185.
  • 7Michel ML, Keller AC ,Paget C, et al. Identification of an IL-17-producing NKI. lneg iNKT cell population involved in airway neutrophilia. J Exp Med,2007,20d-(5) :995-1001.
  • 8Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC ehemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med,2001,194(4) :519-527.
  • 9Happel KI, Dubin PJ, Zheng Met al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med, 2005,202(6) :761-769.
  • 10Yu JJ,Ruddy MJ,Wong GC,et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction : recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent sig- nals. Blood,2007, 109 ( 9 ) : 3794 -3802.

共引文献5

同被引文献30

  • 1刘贤臣,唐茂芹,胡蕾,王爱祯,吴宏新,赵贵芳,高春霓,李万顺.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103-107. 被引量:3323
  • 2冯晶,李雁鹏,赵忠新.睡眠障碍与疼痛[J].第二军医大学学报,2007,28(5):542-544. 被引量:24
  • 3汪向东 王希林 马弘.心理卫生评定量表手册.中国心理卫生杂志,1999,12:217-217.
  • 4Dhingra L, Masson C, Perlman DC, et al. Epidemiology of pain among outpatients in methadone maintenance treatment programs[J]. Drug Alcohol Depend, 2013, 128(1 - 2) : 161 - 165.
  • 5Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities [ J ]. JAMA. 2003. 289 (18) :2370 - 2378.
  • 6Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research[J]. Psychiatry Res, 1989, 28(2) : 193 -213.
  • 7Szezytkowski JL, Lysle DT. Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala[ J]. Eur J Neurosci, 2008, 28(9):1867- 1876.
  • 8Zhang JM, An J. Cytokines, inflammation, and pain [ J ]. Int Anesthesiol Clin, 2007, 45 ( 2 ) :27 - 37.
  • 9Lesniak A, Lipkowski AW. Opioid peptides in peripheral pain control[J]. Acta Neurobiol Exp (Wars), 2011, 71 (1) :129 -138.
  • 10Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward[J]. J Pain, 2013, 14(12) :1539 - 1552.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部